(UroToday.com) At the 2020 European Society for Medical Oncology Virtual Congress (ESMO) virtual annual meeting, Dr. Laurence Albiges provided a discussant presentation for the COSMIC-021 trial and the French BIONIKK trial. The first trial she discussed was presented by Dr. Monty Pal “Cabozantinib in combination with atezolizumab as first-line therapy for advanced clear cell renal cell carcinoma: Results from the COSMIC-021 study”.